• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GraniteShares Launches ISRG and NBIS Leveraged Single-Stock ETFs: ISUL & NBIL

    10/7/25 8:00:00 AM ET
    $ISRG
    $NBIS
    Industrial Specialties
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $ISRG alert in real time by email

    New York, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GraniteShares 2x Long ISRG Daily ETF (ISUL) and GraniteShares 2x Long NBIS Daily ETF (NBIL) Launch Today.

    GraniteShares, a provider of exchange traded funds (ETFs), today announced the launch of two new leveraged single-stock ETFs:

    GraniteShares 2x Long ISRG Daily ETF (NASDAQ:ISUL), and

    GraniteShares 2x Long NBIS Daily ETF (NASDAQ:NBIL)

    An investment in these ETFs provides investors daily leveraged exposure to the two respective underlying stocks: Intuitive Surgical, Inc. (NASDAQ:ISRG) and Nebius Group NV (NASDAQ:NBIS).

    GraniteShares' leveraged ETFs seek daily investment results, before fees and expenses, that correspond to 2 times (200%) the daily percentage change of the respective common stocks. These funds are designed for investors looking to capitalize on short-term movements in the underlying stocks.

     New GraniteShares 2x Leveraged Single-Stock ETFs

    TickerFund NameFund Page URL
    ISULGraniteShares 2x Long ISRG Daily ETFhttps://graniteshares.com/institutional/us/en-us/etfs/isul/
    NBILGraniteShares 2x Long NBIS Daily ETFhttps://graniteshares.com/institutional/us/en-us/etfs/nbil/

     

    Underlying Companies

    • Intuitive Surgical, Inc., (NASDAQ:ISRG) founded in 1995 and based in Sunnyvale, California, develops and markets robotic-assisted technologies that advance minimally invasive care. Its flagship da Vinci Surgical System supports procedures across specialties such as general surgery, urology, gynecology, cardiothoracic, and head and neck, while the Ion endoluminal system enables minimally invasive lung biopsies and extends its reach into diagnostic procedures. The company also provides stapling, energy, and core instruments, training programs, technical support, system monitoring, and digital solutions that enhance hospital performance. Its products are sold worldwide through direct capital and clinical sales teams.



    • Nebius Group N.V., (NASDAQ:NBIS) headquartered in Amsterdam and rebranded from Yandex N.V. in 2024, is a Netherlands-based technology company building full-stack infrastructure for the global AI industry. Its offerings include GPU clusters, cloud platforms, and developer tools supporting AI workloads like generative AI and autonomous vehicles. The company also operates three brands: Toloka for AI data services, TripleTen for tech career reskilling, and Avride for autonomous driving and robotics, serving markets across Europe, North America, and Israel.



    Designed for Tactical Traders

    The new leveraged ETFs provide traders with a tool to gain leveraged exposure to these stocks, making them a potential consideration for those looking to execute short-term tactical trades.

    "We continue to expand our suite of leveraged ETFs to meet the demand for high-conviction trading opportunities," said Will Rhind, Founder of GraniteShares. "With the launch of ISUL, and NBIL, we are providing investors with targeted tools to access some of the most exciting companies in financial services, online brokerage and digital investing."

    For more information on the new GraniteShares leveraged ETFs, read the Prospectus.

    About GraniteShares

    GraniteShares is an entrepreneurial ETF provider focused on high-conviction investment solutions. The firm offers a range of innovative ETFs spanning leveraged, inverse, and high-yield strategies, empowering investors with differentiated tools for portfolio construction. Founded in 2016, GraniteShares has grown rapidly by delivering cutting-edge solutions tailored to modern market needs. For more information, visit www.graniteshares.com.

    Media Contact:

    GraniteShares Inc.

    Attn: Media Relations

    222 Broadway, 21st Floor

    New York, NY 10038

    844-476-8747

    [email protected]

    RISK FACTORS AND IMPORTANT INFORMATION

    This material must be preceded or accompanied by a Prospectus. Carefully consider the Fund's investment objectives risk factors, charges and expenses before investing. Please read the prospectus before investing. The fund does not directly invest in the underlying stock.

    The Fund is recently organized October 07, 2025. As a result, prospective investors do not have a track record or history on which to base their investment decisions. There can be no assurance that the Funds will grow to or maintain an economically viable size.

    The Fund is not suitable for all investors. The investment program of the funds is speculative, entails substantial risks and include asset classes and investment techniques not employed by most ETFs and mutual funds. Investments in the ETFs are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, understand the risks associated with the use of leverage and are willing to monitor their portfolios frequently. For periods longer than a single day, the Fund will lose money if the Underlying Stock's performance is flat, and it is possible that the Fund will lose money even if the Underlying Stock's performance increases over a period longer than a single day. An investor could lose the full principal value of his/her investment within a single day.

    The Fund seeks daily leveraged investment results and are intended to be used as short-term trading vehicles. This Fund attempts to provide daily investment results that correspond to the respective long leveraged multiple of the performance of its underlying stock (a Leverage Long Fund).

    Investors should note that such Leverage Long Fund pursues daily leveraged investment objectives, which means that the Fund is riskier than alternatives that do not use leverage because the Fund magnifies the performance of its underlying stock. The volatility of the underlying security may affect a Funds' return as much as, or more than, the return of the underlying security.

    Because of daily rebalancing and the compounding of each day's return over time, the return of the Fund for periods longer than a single day will be the result of each day's returns compounded over the period, which will very likely differ from 200% of the return of the Underlying Stock over the same period. The Fund will lose money if the Underlying Stock's performance is flat over time, and as a result of daily rebalancing, the Underlying Stock volatility and the effects of compounding, it is even possible that the Fund will lose money over time while the Underlying Stock's performance increases over a period longer than a single day.

    Shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

    An investment in the Fund involves risk, including the possible loss of principal. The Fund is non-diversified and includes risks associated with the Fund concentrating its investments in a particular industry, sector, or geographic region which can result in increased volatility. The use of derivatives such as futures contracts and swaps are subject to market risks that may cause their price to fluctuate over time. Risks of the Fund include Effects of Compounding and Market Volatility Risk, Leverage Risk, Market Risk, Counterparty Risk, Rebalancing Risk, Intra-Day Investment Risk, Other Investment Companies (including ETFs) Risk, and risks specific to the securities of the Underlying Stock and the sector in which it operates. These and other risks can be found in the prospectus.

    This information is not an offer to sell or a solicitation of an offer to buy shares of any Funds to any person in any jurisdiction in which an offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Please consult your tax advisor about the tax consequences of an investment in Fund shares, including the possible application of foreign, state, and local tax laws. You could lose money by investing in the ETFs. There can be no assurance that the investment objective of the Funds will be achieved. None of the Funds should be relied upon as a complete investment program.

    The Fund is distributed by ALPS Distributors, Inc, which is not affiliated with GraniteShares or any of its affiliates ©2025 GraniteShares Inc. All rights reserved. GraniteShares, GraniteShares Trusts, and the GraniteShares logo are registered and unregistered trademarks of GraniteShares Inc., in the United States and elsewhere. All other marks are the property of their respective owners.



    Primary Logo

    Get the next $ISRG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ISRG
    $NBIS

    CompanyDatePrice TargetRatingAnalyst
    Nebius Group N.V.
    $NBIS
    3/24/2026$150.00Buy
    BofA Securities
    Nebius Group N.V.
    $NBIS
    3/16/2026$169.00Buy
    Citigroup
    Intuitive Surgical Inc.
    $ISRG
    3/11/2026$590.00Neutral → Buy
    Citigroup
    Nebius Group N.V.
    $NBIS
    2/18/2026$150.00Buy
    Compass Point
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Nebius Group N.V.
    $NBIS
    1/15/2026$126.00Equal-Weight
    Morgan Stanley
    Intuitive Surgical Inc.
    $ISRG
    12/11/2025$635.00Buy → Neutral
    Citigroup
    Nebius Group N.V.
    $NBIS
    11/19/2025$175.00Mkt Outperform
    Citizens JMP
    More analyst ratings

    $ISRG
    $NBIS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Boynton John Wilson Iv

    3 - Nebius Group N.V. (0001513845) (Issuer)

    3/18/26 9:39:37 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 3 filed by new insider Nave Ophir

    3 - Nebius Group N.V. (0001513845) (Issuer)

    3/18/26 8:26:44 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 3 filed by new insider Tal Boaz

    3 - Nebius Group N.V. (0001513845) (Issuer)

    3/18/26 8:20:07 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Nebius Group N.V. with a new price target

    BofA Securities initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $150.00

    3/24/26 8:49:04 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Citigroup initiated coverage on Nebius Group N.V. with a new price target

    Citigroup initiated coverage of Nebius Group N.V. with a rating of Buy and set a new price target of $169.00

    3/16/26 8:32:38 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Intuitive Surgical upgraded by Citigroup with a new price target

    Citigroup upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $590.00

    3/11/26 8:28:54 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    $NBIS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nebius AI Cloud 3.5 Introduces Serverless AI to Give Developers Frictionless Compute for Real-World AI

    Latest "Aether" platform update enables teams to build, run and scale AI workloads without managing infrastructure Addition of NVIDIA RTX PRO™ 6000 Blackwell Server Edition GPU and Nebius's Data Transfer Service simplify real-world AI deployment Nebius today unveiled Nebius AI Cloud 3.5, adding significant new capabilities to its full-stack cloud platform that reduce operational friction and enable AI builders to prototype, test, and ship products faster. The introduction of serverless features gives developers the ability to launch workloads almost instantly, eliminating the need for AI teams to spend significant time configuring infrastructure before they can run experiments, tra

    3/26/26 12:42:00 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems

    SAN CARLOS, Calif., March 24, 2026 /PRNewswire/ -- Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its second fund, Futures II. The fund includes participation from Mayo Clinic and Sutter Health, reflecting their collective interest in innovative technologies that have the potential to advance the future of patient care by enhancing access, improving quality and transforming the overall patient experience."Through our second fund we'll continue enabling the next wave of companies and he

    3/24/26 11:03:00 AM ET
    $ISRG
    $PRCT
    $SWAV
    Industrial Specialties
    Health Care
    Medical/Dental Instruments

    Nebius Group Announces Closing of Private Offering of Convertible Senior Notes, With Aggregate Gross Proceeds of Approximately $4.3 Billion

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), a leading AI infrastructure company, today announced the closing of its previously announced offering of convertible senior notes, in two series: 1.250% convertible notes due 2031 (the "2031 Notes") and 2.625% convertible notes due 2033 (the "2033 Notes", and together with the 2031 Notes, the "Notes"), in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. The initial purchaser exercised in full its option to purchase an additional $337.5 million aggregate original principal amount of 2031 Notes. Accordingly, the aggregate original principal amount of the 2

    3/23/26 3:31:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Intuitive Surgical Inc.

    SCHEDULE 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    3/27/26 9:55:20 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form 6-K filed by Nebius Group N.V.

    6-K - Nebius Group N.V. (0001513845) (Filer)

    3/20/26 4:19:59 PM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by Nebius Group N.V.

    6-K - Nebius Group N.V. (0001513845) (Filer)

    3/18/26 7:14:51 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    Leadership Updates

    Live Leadership Updates

    View All

    Nebius Names Dan Lawrence to Lead Expansion in the US as Senior Vice President and General Manager for the Americas

    Nebius (NASDAQ:NBIS), the AI cloud company, today announced the appointment of Dan Lawrence as Senior Vice President and General Manager for the Americas. Lawrence will lead the company's rapid North American expansion and scale its commercial organization to meet unprecedented demand for purpose-built AI infrastructure. Based in the Boston area, Lawrence is tasked with significantly scaling Nebius's regional go-to-market engine across four key customer segments: strategic, enterprise, ISV and AI-native. As Nebius continues building out gigawatts of capacity in the US, Lawrence will ramp up the teams and operational foundations required to capture demand in the company's key market and su

    3/9/26 8:00:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Intel Appoints Dr. Craig H. Barratt to Board of Directors

    Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute

    11/10/25 6:21:00 PM ET
    $ALAB
    $INTC
    $ISRG
    Semiconductors
    Technology
    Industrial Specialties
    Health Care

    Marc Boroditsky Joins Nebius as Chief Revenue Officer

    Nebius (NASDAQ:NBIS), a leading AI infrastructure company, today announced the appointment of Marc Boroditsky as Chief Revenue Officer as the company continues to build out its global sales team. A seasoned senior tech executive, Marc has a strong global go-to-market track record of driving high growth – in five years at Twilio he grew paying customers six times, and revenue more than 10 times to $4 billion. Previously he founded several successful companies, and served as a senior leader at Oracle and most recently Cloudflare. Arkady Volozh, founder and CEO of Nebius, welcomed Marc to the company: "We are building a global company and planning to grow many times in the coming years.

    5/28/25 7:30:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    $ISRG
    $NBIS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nebius Group N.V.

    SC 13G/A - Nebius Group N.V. (0001513845) (Subject)

    11/12/24 10:32:14 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/24 10:02:59 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

    SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

    2/14/23 12:37:59 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ISRG
    $NBIS
    Financials

    Live finance-specific insights

    View All

    Nebius Reports Fourth Quarter and Full-Year 2025 Financial Results

    Nebius Group N.V. (NASDAQ:NBIS), the AI cloud company, today announced its unaudited financial results for the fourth quarter and full financial year ended December 31, 2025. The Company today also published founder and CEO Arkady Volozh's quarterly letter to shareholders, available on its investor relations website at https://nebius.com/investor-hub. Management will hold an earnings webcast today at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time). To register, or to listen to the live audio webcast, please visit https://nebius.com/investor-hub. Q4 2025 Financial Highlights Consolidated results (1), (2)        

    2/12/26 8:34:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Nebius Group N.V. Announces Date of Fourth Quarter and Full Year 2025 Results and Conference Call

    Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS) will release its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, before market open. Nebius Group will also hold a conference call to discuss its results at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time / 2:00 p.m. Central European Time) on the same day. The registration link to access the webcast and its replay will be available on Nebius Group's Investor Relations website at https://nebius.com/investor-hub. About Nebius Group Nebius Group (NASDAQ:NBIS) is a technology company building full-stack infrastructure for the global AI industry. Headquartered in Amsterdam and listed on Nas

    2/2/26 2:39:00 AM ET
    $NBIS
    Computer Software: Programming Data Processing
    Technology

    Intuitive Announces Fourth Quarter Earnings

    SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with 493 in the fourth quarter of 2024. The fourth quarter 2025 da Vinci surgical system placements included 303 da Vinci 5 systems, compared with 174 i

    1/22/26 4:05:00 PM ET
    $ISRG
    Industrial Specialties
    Health Care